Table 1.
Prevalence of Plasmodium falciparum based on LM and PfHRP-2/pLDH RDT screening in Mawza District, Taiz Governorate, Yemen
| LM | PfHRP-2/pLDH RDT | ||||
|---|---|---|---|---|---|
| No | n | % (95 % CI) | n | % (95 % CI) | |
| Overall | 488 | 52 | 10.7 (8.2–13.7) | 160 | 32.8 (28.8–37.1) |
| Age (years) | |||||
| ≥10 | 424 | 46 | 10.8 (8.2–14.2) | 136 | 32.1 (27.8–36.7) |
| <10 | 64 | 6 | 9.4 (4.4–19.0) | 24 | 37.5 (26.7–49.8) |
| Fever 48 h prior to screening | |||||
| Yes | 51 | 45 | 88.2 (76.6–94.5) | 48 | 94.1 (84.1–98.0) |
| No | 437 | 7 | 1.6 (1.0–3.3) | 112 | 25.6 (21.8–29.9) |
| History of anti-malarial drug intake 1 week prior to the survey | |||||
| Yes | 157 | 20 | 13.0 (9.0–19.0) | 76 | 48.0 (41.0–56.0) |
| No | 331 | 32 | 10.0 (7.0–13.0) | 84 | 25.0 (21.0–30.0) |
n number positive, CI confidence interval LM light microscopy PfHRP-2 P. falciparum histidine-rich protein-2, pLDH Plasmodium lactate dehydrogenase, RDT rapid diagnostic test